AAPL   322.11 (+1.31%)
MSFT   182.88 (-0.19%)
FB   229.80 (+2.09%)
GOOGL   1,434.79 (+0.09%)
AMZN   2,470.93 (+1.17%)
NVDA   351.88 (-0.88%)
CGC   16.44 (-5.35%)
BABA   206.09 (-0.63%)
MU   46.99 (-1.92%)
GE   6.72 (+2.13%)
TSLA   882.11 (+5.64%)
AMD   53.73 (-0.13%)
T   31.14 (+0.91%)
F   5.87 (+2.80%)
GILD   75.30 (-3.25%)
DIS   118.94 (+1.40%)
NFLX   423.80 (+0.97%)
BAC   24.70 (+2.36%)
BA   150.89 (+3.46%)
AAPL   322.11 (+1.31%)
MSFT   182.88 (-0.19%)
FB   229.80 (+2.09%)
GOOGL   1,434.79 (+0.09%)
AMZN   2,470.93 (+1.17%)
NVDA   351.88 (-0.88%)
CGC   16.44 (-5.35%)
BABA   206.09 (-0.63%)
MU   46.99 (-1.92%)
GE   6.72 (+2.13%)
TSLA   882.11 (+5.64%)
AMD   53.73 (-0.13%)
T   31.14 (+0.91%)
F   5.87 (+2.80%)
GILD   75.30 (-3.25%)
DIS   118.94 (+1.40%)
NFLX   423.80 (+0.97%)
BAC   24.70 (+2.36%)
BA   150.89 (+3.46%)
AAPL   322.11 (+1.31%)
MSFT   182.88 (-0.19%)
FB   229.80 (+2.09%)
GOOGL   1,434.79 (+0.09%)
AMZN   2,470.93 (+1.17%)
NVDA   351.88 (-0.88%)
CGC   16.44 (-5.35%)
BABA   206.09 (-0.63%)
MU   46.99 (-1.92%)
GE   6.72 (+2.13%)
TSLA   882.11 (+5.64%)
AMD   53.73 (-0.13%)
T   31.14 (+0.91%)
F   5.87 (+2.80%)
GILD   75.30 (-3.25%)
DIS   118.94 (+1.40%)
NFLX   423.80 (+0.97%)
BAC   24.70 (+2.36%)
BA   150.89 (+3.46%)
AAPL   322.11 (+1.31%)
MSFT   182.88 (-0.19%)
FB   229.80 (+2.09%)
GOOGL   1,434.79 (+0.09%)
AMZN   2,470.93 (+1.17%)
NVDA   351.88 (-0.88%)
CGC   16.44 (-5.35%)
BABA   206.09 (-0.63%)
MU   46.99 (-1.92%)
GE   6.72 (+2.13%)
TSLA   882.11 (+5.64%)
AMD   53.73 (-0.13%)
T   31.14 (+0.91%)
F   5.87 (+2.80%)
GILD   75.30 (-3.25%)
DIS   118.94 (+1.40%)
NFLX   423.80 (+0.97%)
BAC   24.70 (+2.36%)
BA   150.89 (+3.46%)
Log in

LON:NMCNMC Health Price Target & Analyst Ratings

GBX 5
0.00 (0.00 %)
(As of 04/27/2020)
Add
Compare
Today's Range
5
Now: GBX 5
5
50-Day Range
0.05
MA: GBX 191
938.40
52-Week Range
0.10
Now: GBX 5
3,059
Volume2.02 million shs
Average Volume480,652 shs
Market Capitalization£10.44 million
P/E Ratio0.04
Dividend Yield1.93%
BetaN/A

Analyst Ratings

NMC Health (LON:NMC) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
5 Wall Street analysts have issued ratings and price targets for NMC Health in the last 12 months. Their average twelve-month price target is GBX 3,236.25The high price target for NMC is GBX 4,275 and the low price target for NMC is GBX 500. There are currently 1 sell rating and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.602.602.602.60
Ratings Breakdown: 1 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 3,236.25GBX 3,236.25GBX 3,236.25GBX 3,607.75

NMC Health (LON:NMC) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

NMC Health (LON:NMC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/24/2020Jefferies Financial GroupLower Price TargetUnderperformGBX 1,300 ➝ GBX 500
1/7/2020BarclaysReiterated RatingOverweight
10/28/2019Goldman Sachs GroupLower Price TargetBuyGBX 4,250 ➝ GBX 4,170
9/17/2019Berenberg BankBoost Price TargetBuyGBX 3,600 ➝ GBX 4,000
8/27/2019Societe GeneraleReiterated RatingBuy
10/23/2018HSBCBoost Price TargetBuyGBX 1,430 ➝ GBX 4,600
8/21/2018JPMorgan Chase & Co.Reiterated RatingNeutralGBX 3,270 ➝ GBX 4,060
(Data available from 6/1/2018 forward)
This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.